Sale!

GRHL3 Gene Van der Woude Syndrome Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GRHL3 gene test for Van der Woude Syndrome Type 2 is a specialized genetic examination designed to identify mutations in the GRHL3 gene, which are implicated in the development of Van der Woude Syndrome Type 2 (VWS2). VWS2 is a rare genetic disorder characterized by distinctive facial features, including cleft lip and/or palate, pits or mounds of the lower lip, and sometimes missing teeth or other dental abnormalities. The condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.

This genetic test is crucial for families with a history of VWS2, as it can provide definitive confirmation of the diagnosis, inform clinical management, and guide genetic counseling. Early diagnosis through genetic testing can significantly benefit affected individuals, allowing for timely intervention and support for associated symptoms.

The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the GRHL3 gene test for Van der Woude Syndrome Type 2 at DNA Labs UAE is 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify mutations in the GRHL3 gene. Upon completion, the results from this test can offer valuable insights for affected individuals and their families, aiding in the management of the condition and planning for future family planning decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GRHL3 Gene van der Woude syndrome type 2 Genetic Test

Are you concerned about Van der Woude syndrome type 2? DNA Labs UAE offers the GRHL3 Gene van der Woude syndrome type 2 Genetic Test to help diagnose this rare genetic disorder.

Test Details

The GRHL3 gene is associated with Van der Woude syndrome type 2, a condition characterized by cleft lip and/or cleft palate. Our NGS (Next-Generation Sequencing) genetic testing technique allows for the simultaneous analysis of multiple genes to identify any mutations or variations that may be present.

Test Components and Price

Components: GRHL3 Gene van der Woude syndrome type 2 Genetic Test

Price: 4400.0 AED

Sample Condition

Sample: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

Report Delivery Time: 3 to 4 Weeks

Method

Method: NGS Technology

Test Type

Test Type: Dysmorphology

Doctor and Test Department

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information

Before undergoing the GRHL3 Gene van der Woude syndrome type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. A Genetic Counselling session may be conducted to draw a pedigree chart of family members affected by the condition.

Test Process

During the NGS genetic test, a DNA sample is collected, usually through a blood sample or saliva sample. The DNA is then sequenced using NGS technology, which allows for the simultaneous analysis of multiple genes. The sequencing data is compared to a reference genome to identify any variations or mutations in the GRHL3 gene.

Benefits of the Test

The NGS genetic testing for GRHL3 gene mutations can help diagnose Van der Woude syndrome type 2 and provide information about the specific genetic variant causing the condition. This information can be useful for genetic counseling, family planning, and potentially guiding treatment decisions.

Additional Information

It’s important to note that NGS genetic testing may not always identify a mutation or variation in the GRHL3 gene, as not all genetic causes of Van der Woude syndrome type 2 are known. In some cases, additional testing or evaluation may be needed to confirm a diagnosis. Genetic testing should always be done under the guidance of a healthcare professional or genetic counselor.

Don’t let uncertainty linger. Get the GRHL3 Gene van der Woude syndrome type 2 Genetic Test at DNA Labs UAE and gain valuable insights into your genetic makeup.

Test Name GRHL3 Gene van der Woude syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GRHL3 Gene van der Woude syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GRHL3 Gene van der Woude syndrome type 2 NGS Genetic DNA Test gene GRHL3
Test Details

The GRHL3 gene is associated with Van der Woude syndrome type 2, which is a rare genetic disorder characterized by cleft lip and/or cleft palate. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify any mutations or variations that may be present.

NGS genetic testing for GRHL3 gene mutations can help diagnose Van der Woude syndrome type 2 and provide information about the specific genetic variant causing the condition. This information can be useful for genetic counseling, family planning, and potentially guiding treatment decisions.

During the NGS genetic test, a DNA sample is collected, usually through a blood sample or saliva sample. The DNA is then sequenced using NGS technology, which allows for the simultaneous analysis of multiple genes. The sequencing data is then compared to a reference genome to identify any variations or mutations in the GRHL3 gene.

If a mutation or variation is identified in the GRHL3 gene, it can confirm a diagnosis of Van der Woude syndrome type 2. Additionally, it can provide information about the specific mutation, such as its location and potential functional impact. This information can be helpful for understanding the underlying cause of the condition and potentially developing targeted treatments in the future.

It’s important to note that NGS genetic testing may not always identify a mutation or variation in the GRHL3 gene, as not all genetic causes of Van der Woude syndrome type 2 are known. In some cases, additional testing or evaluation may be needed to confirm a diagnosis. Genetic testing should always be done under the guidance of a healthcare professional or genetic counselor.